A detailed history of Raymond James & Associates transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 86,931 shares of ZBH stock, worth $9.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
86,931
Previous 108,105 19.59%
Holding current value
$9.74 Million
Previous $11.7 Million 20.02%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$104.47 - $116.17 $2.21 Million - $2.46 Million
-21,174 Reduced 19.59%
86,931 $9.38 Million
Q2 2024

Jul 19, 2024

BUY
$106.25 - $130.01 $535,393 - $655,120
5,039 Added 4.89%
108,105 $11.7 Million
Q1 2024

Apr 22, 2024

SELL
$119.98 - $132.61 $2.74 Million - $3.03 Million
-22,827 Reduced 18.13%
103,066 $13.6 Million
Q4 2023

Jan 16, 2024

SELL
$102.72 - $121.7 $9.59 Million - $11.4 Million
-93,401 Reduced 42.59%
125,893 $15.3 Million
Q3 2023

Oct 24, 2023

SELL
$110.76 - $143.18 $3.31 Million - $4.28 Million
-29,872 Reduced 11.99%
219,294 $24.6 Million
Q2 2023

Jul 25, 2023

SELL
$126.43 - $145.6 $570,705 - $657,238
-4,514 Reduced 1.78%
249,166 $36.3 Million
Q1 2023

Apr 14, 2023

BUY
$121.91 - $130.94 $9.51 Million - $10.2 Million
77,992 Added 44.39%
253,680 $32.8 Million
Q4 2022

Feb 08, 2023

BUY
$104.7 - $128.4 $1.5 Million - $1.84 Million
14,351 Added 8.9%
175,688 $22.4 Million
Q3 2022

Oct 25, 2022

SELL
$101.65 - $119.27 $4.69 Million - $5.5 Million
-46,102 Reduced 22.22%
161,337 $16.9 Million
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $16.8 Million - $22 Million
-164,332 Reduced 44.2%
207,439 $21.8 Million
Q1 2022

May 11, 2022

BUY
$108.42 - $129.58 $5.15 Million - $6.16 Million
47,542 Added 14.66%
371,771 $47.5 Million
Q4 2021

Feb 08, 2022

BUY
$115.43 - $146.63 $3.45 Million - $4.38 Million
29,852 Added 10.14%
324,229 $41.2 Million
Q3 2021

Nov 02, 2021

BUY
$136.35 - $158.76 $3.47 Million - $4.04 Million
25,447 Added 9.46%
294,377 $43.1 Million
Q2 2021

Aug 11, 2021

BUY
$152.95 - $173.41 $6.75 Million - $7.65 Million
44,101 Added 19.62%
268,930 $43.3 Million
Q1 2021

May 14, 2021

BUY
$148.16 - $159.71 $6.54 Million - $7.05 Million
44,156 Added 24.44%
224,829 $36 Million
Q4 2020

Feb 12, 2021

SELL
$128.25 - $151.41 $8.32 Million - $9.82 Million
-64,881 Reduced 26.42%
180,673 $27.8 Million
Q3 2020

Nov 04, 2020

SELL
$113.59 - $141.68 $1.33 Million - $1.66 Million
-11,722 Reduced 4.56%
245,554 $33.4 Million
Q2 2020

Jul 28, 2020

BUY
$87.02 - $133.4 $60,217 - $92,312
692 Added 0.27%
257,276 $30.7 Million
Q1 2020

Apr 21, 2020

BUY
$78.28 - $155.73 $499,504 - $993,713
6,381 Added 2.55%
256,584 $25.9 Million
Q4 2019

Feb 12, 2020

BUY
$127.4 - $146.83 $10.6 Million - $12.2 Million
83,095 Added 49.73%
250,203 $37.5 Million
Q3 2019

Nov 07, 2019

BUY
$113.33 - $138.46 $3 Million - $3.67 Million
26,489 Added 18.84%
167,108 $22.9 Million
Q2 2019

Aug 06, 2019

BUY
$108.87 - $125.09 $2.86 Million - $3.29 Million
26,272 Added 22.98%
140,619 $16.6 Million
Q1 2019

May 06, 2019

BUY
$97.5 - $125.79 $539,662 - $696,247
5,535 Added 5.09%
114,347 $14.6 Million
Q4 2018

Feb 11, 2019

BUY
$94.4 - $126.76 $873,011 - $1.17 Million
9,248 Added 9.29%
108,812 $11.3 Million
Q3 2018

Nov 14, 2018

BUY
$108.41 - $127.64 $281,107 - $330,970
2,593 Added 2.67%
99,564 $13.1 Million
Q2 2018

Aug 14, 2018

BUY
$102.12 - $114.04 $132,041 - $147,453
1,293 Added 1.35%
96,971 $10.8 Million
Q1 2018

May 14, 2018

BUY
$104.31 - $124.46 $20,757 - $24,767
199 Added 0.21%
95,678 $10.4 Million
Q4 2017

Feb 14, 2018

SELL
$105.55 - $120.83 $1.6 Million - $1.83 Million
-15,156 Reduced 13.7%
95,479 $11.5 Million
Q3 2017

Nov 13, 2017

SELL
$106.92 - $117.79 $1.53 Million - $1.69 Million
-14,332 Reduced 11.47%
110,635 $13 Million
Q2 2017

Aug 14, 2017

BUY
N/A
124,967
124,967 $16 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.5B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.